- Category
- Micro (2020-21)
- Udyam number
- UDYAM-UK-12-0001175

Henro Pharmaceuticals Private Limited
About Henro Pharmaceuticals Private Limited
Data last updated:
Henro Pharmaceuticals Private Limited is a private limited company based in Khatima, Uttarakhand, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 30 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24239UR2020PTC011553. Its GSTIN is 05AAFCH4658B1ZU (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Navneet Kaur Khinda and Harjinder Singh Khinda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Harjindra Singh Adarsh Colony Bhoor Moholiya, Khatima, Uttarakhand, India – 262308.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.7 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹6.51 Lakh (net margin -25.3%) and EBITDA of -₹3.18 Lakh (EBITDA margin -12.4%). Revenue has grown at a compounded annual rate (CAGR) of 77% over three years.
As per MCA filings, the company has open charges of ₹30 Lakh on record.
Henro Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-12-0001175).
Company details
Recognitions & Rankings of Henro Pharmaceuticals
Contact details
Henro Pharmaceuticals Private Limited's registered office is in Khatima, Uttarakhand.
- Registered AddressC/O Harjindra Singh Adarsh Colony Bhoor Moholiya, Khatima, Uttarakhand, India – 262308
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Henro Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Henro Pharmaceuticals Private Limited, buy the company report.
Financials of Henro Pharmaceuticals Private Limited
FY 2025 filings availableHenro Pharmaceuticals Private Limited reported revenue of ₹25.7 Lakh (down 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 18% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 77%. EBITDA fell 264% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.18 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹6.51 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -12.4% | |||
| Net Profit Margin | -25.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Henro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Henro Pharmaceuticals Private Limited
Henro Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navneet Kaur Khinda | Director | 30 Sep 2020 | 6 Years 1 Months | Current |
| Harjinder Singh Khinda | Director | 30 Sep 2020 | 6 Years 1 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2021 | 100486389 | Others | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Henro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Henro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Henro Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAFCH4658B1ZU | Uttarakhand | Active | 28 Nov 2020 |
To see the full GST registrations and return filing status of Henro Pharmaceuticals Private Limited, buy the company report.
Recent activity
Henro Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Harjinder Singh Khinda was appointed as Director on 30 Sep 2020.
Frequently asked questions
Henro Pharmaceuticals is an active private limited company based in Khatima, Uttarakhand, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 30 September 2020 (6+ years old) and is registered under CIN U24239UR2020PTC011553.
Henro Pharmaceuticals has 2 current directors:
- Navneet Kaur Khinda - Director
- Harjinder Singh Khinda - Director
The latest financial statements of Henro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Henro Pharmaceuticals is 05AAFCH4658B1ZU, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Henro Pharmaceuticals is U24239UR2020PTC011553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Henro Pharmaceuticals was incorporated on 30 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Harjinder Singh Khinda was appointed as Director on 30 Sep 2020. Navneet Kaur Khinda was appointed as Director on 30 Sep 2020.
Yes, Henro Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-12-0001175).
The registered office of Henro Pharmaceuticals is at CO Harjindra Singh Adarsh Colony Bhoor Moholiya, Khatima, Uttarakhand, India – 262308.
Henro Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

